An interactive case study for healthcare professionals exploring why insomnia in ASD is a priority, the importance of sleep and how to achieve positive outcomes.
There is a general acceptance of the benefits of solid dosage forms over liquid dosage forms for stability, dosing, and administration issues1.
This booklet provides healthcare professionals with a concise summary of the drawbacks of prescribing liquid melatonin in children, with the support of clinical data.
1. European Medicines Agency, Guideline on pharmaceutical development of medicines for paediatric use, 2013. (Accessed November 2022)
Information for parents of children who may have characteristics or symptoms suggestive of ADHD and/or ASD.
